![]() |
|
|
Vol. 304, Issue 1, 425-432, January 2003
Department of Pharmacology, Weill Medical College of Cornell
University, New York, New York (K.Z., G.L., G.-M.Z., H.H.S.); and
Clinical Research Institute of Montreal, Montreal, Quebec, Canada
(P.W.S.)
Oligopeptides are generally thought to have poor permeability across
biological membranes. Recent studies, however, suggest significant
distribution of [Dmt1]DALDA
(Dmt-D-Arg-Phe-Lys-NH2; Dmt is
2',6'-dimethyltyrosine), a 3+ net charge opioid peptide, to the brain
and spinal cord after subcutaneous administration. Peptide transporters
(PEPT1 and PEPT2) play a major role in the uptake of di- and
tripeptides across cell membranes, but their ability to transport
tetrapeptides is not clear. The purpose of this study was to determine
whether [Dmt1]DALDA can translocate across Caco-2 cell
monolayers and whether PEPT1 plays a role in the uptake process. Our
results show that [3H][Dmt1]DALDA can
readily translocate across Caco-2 cells, with a permeability coefficient estimated to be 1.24 × 10
5 cm/s. When
incubated with Caco-2 cells,
[3H][Dmt1]DALDA was detected in cell
lysates by 5 min. The internalization of [Dmt1]DALDA was
confirmed visually with a fluorescent [Dmt1]DALDA analog
(H-Dmt-D-Arg-Phe-dnsDap-NH2; dnsDap is
-dansyl-L-
,
-diaminopropionic acid). The uptake of
[3H][Dmt1]DALDA was concentration-dependent
but temperature- and pH-independent. Treatment with
diethylpyrocarbonate (DEPC) inhibited
[14C]glycine-sarcosine uptake but increased
[3H][Dmt1]DALDA uptake 34-fold. These
findings suggest that PEPT1 is not involved in
[Dmt1]DALDA internalization. [Dmt1]DALDA
uptake was also observed in SH-SY5Y, human embryonic kidney 293, and
CRFK cells, and was independent of whether the cells expressed
opioid receptors. The efflux of
[3H][Dmt1]DALDA from Caco-2 cells was
temperature-dependent and was inhibited by DEPC, but was not affected
by verapamil, an inhibitor of P-glycoprotein. These data show
transcellular translocation of a highly polar 3+ charge tetrapeptide
and suggest that [Dmt1]DALDA may not only distribute
across the blood-brain barrier but also it may even have reasonable
oral absorption.
This article has been cited by other articles:
![]() |
Y. Mizuguchi, J. Chen, S. V. Seshan, D. P. Poppas, H. H. Szeto, and D. Felsen A novel cell-permeable antioxidant peptide decreases renal tubular apoptosis and damage in unilateral ureteral obstruction Am J Physiol Renal Physiol, November 1, 2008; 295(5): F1545 - F1553. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Famous, V. Kumaresan, G. Sadri-Vakili, H. D. Schmidt, D. F. Mierke, J.-H. J. Cha, and R. C. Pierce Phosphorylation-Dependent Trafficking of GluR2-Containing AMPA Receptors in the Nucleus Accumbens Plays a Critical Role in the Reinstatement of Cocaine Seeking J. Neurosci., October 22, 2008; 28(43): 11061 - 11070. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Thomas, C. Stauffer, K. Zhao, H. Yang, V. K. Sharma, H. H. Szeto, and M. Suthanthiran Mitochondrial Targeting with Antioxidant Peptide SS-31 Prevents Mitochondrial Depolarization, Reduces Islet Cell Apoptosis, Increases Islet Cell Yield, and Improves Posttransplantation Function J. Am. Soc. Nephrol., January 1, 2007; 18(1): 213 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Zhao, G.-M. Zhao, D. Wu, Y. Soong, A. V. Birk, P. W. Schiller, and H. H. Szeto Cell-permeable Peptide Antioxidants Targeted to Inner Mitochondrial Membrane inhibit Mitochondrial Swelling, Oxidative Cell Death, and Reperfusion Injury J. Biol. Chem., August 13, 2004; 279(33): 34682 - 34690. [Abstract] [Full Text] [PDF] |
||||